Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Prevention Research
Cancer Prevention Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Article

Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer

Ensaf M. Al-Hujaily, Yong Tang, De-Sheng Yao, Euridice Carmona, Kenneth Garson and Barbara C. Vanderhyden
Ensaf M. Al-Hujaily
1Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada.
3King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Tang
4Department of Urology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
De-Sheng Yao
5Department of Gynecologic Oncology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Euridice Carmona
6Centre de recherche du Centre hospitalier de l'Université de Montréal, Institut du cancer de Montréal, Montréal, Québec, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Garson
1Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara C. Vanderhyden
1Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada.
2Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bvanderhyden@ohri.ca
DOI: 10.1158/1940-6207.CAPR-15-0121-T Published December 2015
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    PAX2 actions in M0505 mOSE cells. A, Western blot analysis confirming that M0505 transduced with a PAX2 expression vector (PAX2) shows increased PAX2 relative to controls: WPI vector or cre-mediated PAX2 deletion (PAX2 + Cre). B, PAX2 increases M0505 proliferation. C and D, PAX2 increases viable cell number and % viability after 48 hours in growth factor- and serum-free media (starvation). E, PAX2 enhances M0505 cisplatin resistance. For all experiments, n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    PAX2 inhibits p53 induction in mOSE cells. Western blot analysis (A) and densitometric analysis (B) of p53 in M0505 and M1102 cells after cisplatin treatment (12.5 μg/mL; 48 hours), with UV-exposed mouse embryonic fibroblasts as a positive control. C, Trp53 mRNA levels after PAX2 expression. For all experiments, n = 3; *, P < 0.05; **, P < 0.01.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    IPA showing biologic functions associated with gene expression changes after PAX2 expression. Relationships between genes are color-coded by predicted interaction (see legend).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    PAX2 actions in RM and STOSE mouse ovarian cancer cells. A, Western blot analysis confirming PAX2 induction in both cell lines. B, proliferation of STOSE and RM cells with PAX2 induction (PAX2) versus controls (parental, WPI, PAX2-Cre). C, viability (left, alamar blue) and cleaved caspase-3 (right, Western blotting) were assessed after 48-hour cisplatin treatment (n = 3; **, P < 0.01; ****, P < 0.0001). D, PAX2 expression decreased colony formation ability of STOSE but not RM cells (n = 3; ****, P < 0.0001). E and F, Kaplan–Meier survival curves for mice injected with (E) RM + WPI or RM + PAX2 cells or (F) STOSE + WPI, STOSE + PAX2, or STOSE + PAX2 + Cre cells (****, P < 0.0001). G, PAX2 expression decreased STOSE tumor weight at endpoint (**, P < 0.01; *, P < 0.05).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    PAX2 inhibited p53 accumulation in RM but not in STOSE tumors. A, PAX2 expression abolished p53 and cleaved caspase-3 (Western blotting) in all RM + PAX2 tumors examined. Positive controls for p53 and cleaved caspase-3 were cisplatin-treated normal and p53-deficient mOSE, respectively. B, Trp53 mRNA levels in RM and STOSE tumors. C, STOSE tumors did not show p53 accumulation (Western blotting). D, tumor proliferation was examined by immunohistochemistry for Ki67 (quantified in histograms). E, PAX2 expression reduced Htra1 transcripts in mOSE cells and RM tumors, but not STOSE tumors. F, PAX2 expression reduced PTEN levels in RM tumors (Western blotting). G, immunoblot detection of total and phospho-AKT following AKT immunoprecipitation in RM tumors. H, Western blot analysis shows PAX2-associated phosphorylation of ERK1/2 at Thr202 and Tyr204 in RM but not STOSE tumors; SCC25 head and neck carcinoma cells were used as a positive control for EGFR. EGF-treated SCC25 cells were used as positive and (with an EGF inhibitor) negative controls for pERK1/2.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Effect of PAX2 on COX2 and angiogenesis. A, COX2 in ovarian tumors after PAX2 induction (Western blotting). B, MVD was examined using immunohistochemistry for CD31. Bottom, CD31-positive pixel selection, quantified in the histograms on the right (*, P < 0.05). Scale bar, 100 μm. C, a proposed model for PAX2 actions in normal and cancerous ovarian cells. Dotted lines indicate predicted functional effects.

Additional Files

  • Figures
  • Supplementary Data

    • Supplementary data - Supplementary Table 1: Primer pairs (forward [F] and reverse [R]) that were used to amplify murine genes. Supplementary Table 2: The primary antibodies that were used for western blot analysis in the current studies. Supplementary Table 3: The top 10 genes upregulated and downregulated by PAX2 in MO505 cells, as shown by microarray analysis, and their known relationships to ovarian tumorigenesis. Supplementary Table 4: Functional analysis of genes that were changed in M0505+PAX2 cells compared to M0505+WPI and M0505+PAX2+Cre and are involved in tumor growth and progression.
    • Supplementary Figure 1 - IHC analysis shows that PAX2 is expressed in the epithelium of the murine oviduct and uterus, but not in the ovary.
    • Supplementary Figure 2 - PAX2 enhances proliferation and survival in normal mOSE cells.
    • Supplementary Figure 3 - Expression of PAX2 in p53-null cells enhanced proliferation but not survival.
    • Supplementary Figure 4 - Western blot analysis showing there is no T-antigen expression in RM tumors.
PreviousNext
Back to top
Cancer Prevention Research: 8 (12)
December 2015
Volume 8, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Prevention Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
(Your Name) has forwarded a page to you from Cancer Prevention Research
(Your Name) thought you would be interested in this article in Cancer Prevention Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
Ensaf M. Al-Hujaily, Yong Tang, De-Sheng Yao, Euridice Carmona, Kenneth Garson and Barbara C. Vanderhyden
Cancer Prev Res December 1 2015 (8) (12) 1163-1173; DOI: 10.1158/1940-6207.CAPR-15-0121-T

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
Ensaf M. Al-Hujaily, Yong Tang, De-Sheng Yao, Euridice Carmona, Kenneth Garson and Barbara C. Vanderhyden
Cancer Prev Res December 1 2015 (8) (12) 1163-1173; DOI: 10.1158/1940-6207.CAPR-15-0121-T
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Lifestyle and genetic risk and colorectal neoplasms
  • Targeting CD40 and PD-1/PD-L1 Inhibits OPL Progression to OSCC
  • Screening for Pancreatic Ductal Adenocarcinoma
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Prevention Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Prevention Research
eISSN: 1940-6215
ISSN: 1940-6207

Advertisement